GDAN Launch – Here to Help You
On Friday, 8 March, at the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Florence, Italy, GDAN was launched. In front of nearly 70 healthcare professionals, industry stakeholders and diabetes advocates, plus many more online, the joint initiative of the Diabetes Leadership Council (DLC) and PDGN welcomed a panel of parliamentarians and people with […]
EU Effort to Reduce Medicine Costs
In search of more affordable medicines, the European Commission has proposed increase competition and to make generic and bio-similar medicines more readily available across the European Union. The use of generic and substitution drugs is well established in some EU countries, but not others and range from nearly 70 percent in Italy to under 20 […]
Italy 1st to Introduce T1 Screening for Children
The Italian government has become the first to introduce a National Paediatric Screening Law for type 1 diabetes. Introduced by the Vice-President of the Chamber of Deputies, Giorgio Mulè, the law was approved in the Health Commission. It is hoped the screening will help prevent children aged 1 to 17 most likely to be diagnosed […]
Italy First to Introduce T1 Screening
The Italian Parliament has passed a law to make it possible, from 2024, to prevent the occurrence of the most dangerous complications, such as diabetic ketoacidosis, in Italian children between 1 and 17 years old, who are destined to develop type 1 diabetes. The law was celebrated at the October ISPAD annual conference in Rotterdam. […]
More News In Brief
Diabetic Retinopathy in 30% of Italian Patients At a meeting during the XI National Conference of the AMD Foundation held in Rome, Graziano Di Cianni, president of the Association of Diabetic Doctors in Italy (ADDI) raised concerns that 30 percent of patients with diabetes are also affected by diabetic retinopathy. Diabetic retinopathy is a serious […]